Serving leading biopharmaceutical companies globally:

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Drug Sales Trends for TRIAZOLAM

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Payment Methods and Pharmacy Types for TRIAZOLAM (2017)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$14,504,689
INSIDE ANOTHER STORE	$3,390,928
[disabled in preview]	$94,313,918
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	90,350
INSIDE ANOTHER STORE	311,992
[disabled in preview]	999,053
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICARE	$11,663,030
PRIVATE INSURANCE	$80,563,779
[disabled in preview]	$21,633,062
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for TRIAZOLAM

Drug Units Sold Trends for TRIAZOLAM

Annual Sales Revenues and Units Sold for TRIAZOLAM

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Start Trial
Drug Name	Revenues (USD)	Units	Year
TRIAZOLAM	Start Trial	Start Trial	2017
TRIAZOLAM	Start Trial	Start Trial	2016
TRIAZOLAM	Start Trial	Start Trial	2015
TRIAZOLAM	Start Trial	Start Trial	2014
TRIAZOLAM	Start Trial	Start Trial	2013
TRIAZOLAM	Start Trial	Start Trial	2012
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

McKinsey

McKesson

Merck

AstraZeneca

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.